Mortality and morbidity in different immunization protocols for experimental autoimmune myocarditis in rats
- 11 January 2014
- journal article
- research article
- Published by Wiley in Acta Physiologica
- Vol. 210 (4) , 889-898
Abstract
Aim We aimed to investigate the histological and clinical presentations of experimental autoimmune myocarditis (EAM) induced by different immunization schemes. Methods Male young Lewis rats were divided into five groups immunized by porcine myocardial myosin: subcutaneously (SC) 2 mg (in two 1‐mg doses on day 0 and 7), 0 mg (sham group) subcutaneously into rear footpads (RF), 0.25 mg RF, 0.5 mg RF or 1 mg RF (all RF once on day 0). On day 21, left ventricular (LV) function was assessed by cardiac magnetic resonance imaging and cardiac catheterization. The type and degree of myocardial inflammatory infiltrates were determined by conventional histology and immunohistochemistry. Results In the SC immunized rats and in the RF sham group, we observed 0% mortality, while in the actively RF immunized rats, mortality was 20, 20 and 44% for the 0.25 mg, 0.5 mg and 1 mg myosin doses respectively. Morbidity as defined by inflammatory infiltrates on haematoxylin and eosin (HE) staining was 22% in the SC immunized rats, 0% in the RF sham group and 100% in all actively RF immunized groups. We observed augmented relative ventricle weight and spleen weight, increased LV end‐diastolic pressure, reduced LV developed pressure and reduced LV ejection fraction in all with myosin‐immunized RF groups without any systematic dose effect. Conclusion Subcutaneous immunization to the neck and flanks did not induce a reproducible EAM, while RF myosin administration reliably led to EAM. Lower myosin doses seem to induce the complete histological and clinical picture of EAM while being associated with lower mortality, non‐specific symptoms and animal distress.Keywords
This publication has 35 references indexed in Scilit:
- Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide productionInternational Journal of Cardiology, 2013
- Correlation of left ventricular wall thickness, heart mass, serological parameters and late gadolinium enhancement in cardiovascular magnetic resonance imaging of myocardial inflammation in an experimental animal model of autoimmune myocarditisThe International Journal of Cardiovascular Imaging, 2012
- Modulation of endoplasmic reticulum stress and cardiomyocyte apoptosis by mulberry leaf diet in experimental autoimmune myocarditis ratsJournal of Clinical Biochemistry and Nutrition, 2012
- Accuracy of cardiovascular magnetic resonance in myocarditis: comparison of MR and histological findings in an animal modelJournal of Cardiovascular Magnetic Resonance, 2010
- Suppression of Inflammation in Rat Autoimmune Myocarditis by S100A8/A9 Through Modulation of the Proinflammatory Cytokine NetworkEuropean Journal of Heart Failure, 2009
- A specific inhibitor of plasminogen activator inhibitor-1 suppresses rat autoimmune myocarditisExpert Opinion on Therapeutic Targets, 2008
- CNP infusion attenuates cardiac dysfunction and inflammation in myocarditisBiochemical and Biophysical Research Communications, 2007
- Peroxisome Proliferator-Activated Receptor-γ Ligands Ameliorate Experimental Autoimmune Myocarditis Associated with Inhibition of Self-Sensitive T CellsJournal of Cardiovascular Pharmacology, 2004
- FK506 therapy of experimental autoimmune myocarditis after onset of the diseaseAmerican Heart Journal, 1993
- A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fractionClinical Immunology and Immunopathology, 1990